No abstract

Borderline personality disorder (BPD) is a prevalent condition today. The studies carried out about its evaluation and treatment are aimed at the adolescent and adult population, however, there is not enough information in the elderly. In these, symptoms related to emotional instability and interpersonal performance predominate, different from the clinic of the categorical prototype in young people. No further research has been developed on effective treatment for this age group with personality disorder; however, it seems that the use of psychotropic drugs and psychotherapy is useful for those with associated comorbidities.

In daily medical practice there are several special situations against the prescription of benzodiazepines as common in all specialties, however, despite knowledge of their side effects there is controversy and difficulty in the management of geriatric patients. In this way, this is an opportunity through a critical review of the existing literature about the effect of benzodiazepines in the elderly.

The consumption of energy drinks and their rapid expansion has created concern from a scientific and community point of view. These are drinks that contain caffeine as their most common active ingredient. We present the case of a patient with no psychiatric history with clinical presentation of psychotic symptoms after increased consumption of energy drinks. A review of existing literature is carried out on other cases of the appearance of psychosis after the consumption of these beverages in people without and with a psychiatric history, as well as cases in which the presentation of other psychiatric symptoms predominates in order to discuss the clinical impact. The consumption of energy drinks could represent a global public health problem due to the possible serious and still little studied adverse effects on physical and mental health.

Introduction: Bipolar disorder and borderline personality disorder are diagnoses that have a wide variety of symptoms, however, it is described that the comorbidity of both intensifies the clinical severity as the appearance of a greater number of suicide attempts or self-harm. The objective of the study was to determine and compare the sociodemographic characteristics, clinical severity and symptoms in patients within these 3 groups. Method: The type of study was descriptive and qualitative, observational and transversal design. A sample of 92 clinical records of patients treated at the National Hospital Víctor Larco Herrera during the periods of January 2010 to May 2018 was used. Sociodemographic variables (age, sex, marital status, religion, level of education and occupation) and clinical severity (number of hospitalizations, suicide attempts, refusal of medication, response to treatment, substance abuse, current hospitalization and severity symptoms) using a data collection form. Results: The sociodemographic variables with statistical significance and higher frequency were female sex (p = 0.049), single marital status (p = 0.003), catholic religion (p = 0.009), as well as the variables of clinical severity with statistical significance were the number of hospitalizations (p = 0.015), psychotic symptoms (p = 0.009), irritability (p = 0.038), impairment (p = 0.000) and number of symptoms of severity (p = 0.030) in TB, BPD and their comorbidity. Conclusions: The clinical severity is associated with the number of hospitalizations, the presence of psychotic symptoms, irritability, dysfunctionality and the number of severe symptoms in patients with only TB diagnosis, BPD and their comorbidity.